Navigation Links
Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing
Date:1/28/2008

ies. Mr. Bennett earned his MBA from Pepperdine University and his B.S. in Industrial Technology from California State University, Long Beach.

"I am very excited to join Allos and lead the Company's manufacturing activities," said Mr. Bennett. "I believe Allos has the product candidates and leadership team to make a potentially significant impact in the development of new therapies for the treatment of cancer."

About Allos Therapeutics, Inc.

Allos Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer. The Company's lead product candidate, PDX (pralatrexate), is a novel antifolate currently under evaluation in a pivotal Phase 2 (PROPEL) trial in patients with relapsed or refractory peripheral T-cell lymphoma. The PROPEL trial is being conducted under an agreement reached with the U.S. Food and Drug Administration under its special protocol assessment, or SPA process. The Company is also investigating PDX in patients with non-small cell lung cancer and a range of lymphoma sub-types. The Company's other product candidate is RH1, a targeted chemotherapeutic agent currently being evaluated in a Phase 1 trial in patients with advanced solid tumors or non-Hodgkins Lymphoma (NHL). For additional information, please visit the Company's website at http://www.allos.com.

Safe Harbor Statement

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements relating to Mr. Bennett's potential impact on the future growth and success of the Company; the potential safety, efficacy and marketability of the Company's product candidates; and other statements that are other than statements of historical facts. In some cases, you can identify forward-looking s
'/>"/>

SOURCE Allos Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Allos Therapeutics to Present at the 2007 RBC Capital Markets Healthcare Conference
2. Allos Therapeutics Reports Third Quarter 2007 Financial Results
3. Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference
4. Ocera Therapeutics Receives Orphan Drug Status for AST-120 for Pouchitis
5. Transition Therapeutics Announces Appointment of Vice-President of Business Development
6. Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
7. Transition Therapeutics Announces Milestone Payment from Elan
8. ImaRx Therapeutics Submits Urokinase Data to FDA Supporting Extended Expiration Dating
9. Reckitt Benckiser Commences Cash Tender Offer for All Outstanding Shares of Adams Respiratory Therapeutics
10. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
11. Dr. Peter B. Corr Joins Team at Celtic Therapeutics as General Partner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 02, 2015 On Wednesday, May 27, 2015, ... to a top speed of 207.9 mph. In the ... to break the 200 mph mark. Jay Leno was ... upcoming episode of Jay Leno’s Garage, which will air on ... the 8.5 mile high speed oval at the Continental Tire ...
(Date:6/2/2015)... UCLA Health and Exer have completed ... and expand urgent care services in Los Angeles County. ... University of California Board of Regents and the Exer ... Health to purchase a minority share of four existing ... Park and Northridge and creates opportunity to grow and ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 TMG Health, ... for health plans in the Medicare Advantage, Medicare Part ... a sponsor and exhibitor at AHIP’s Institute 2015, the ... Insurance Plans. The conference will be held June 3-5 ... #1303, will offer opportunities for attendees to schedule private ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 On October ... congressional efforts for another delay. , On Monday, ... Health Subcommittee for the House Ways and Means Committee, ... to Centers for Medicare and Medicaid Services, urging the ... as CMS rolls out ICD-10. ICD-10 is the newest ...
(Date:6/2/2015)... 02, 2015 IMPAK Corporation, a ... has announced the availability of “child-resistant” pouches and ... by children, especially curious toddlers. The Child Resistant ... tested to CFR 1700.20 protocols. The announcement was ... Looks Like Candy, “With the proliferation of consumer ...
Breaking Medicine News(10 mins):Health News:774 HP Hennessey Mustang Tested to 207.9 mph 2Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:TMG Health to Sponsor and Exhibit at AHIP’s Institute 2015 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2
... , , CHADDS FORD, Pa., Aug. 31 ... at the Thomas Weisel Partners Healthcare Conference 2009 on Thursday, Sept. 10, 2009, ... review the company,s products and development programs. , , The ... www.endo.com under the investors section. , ...
... , , VENTURA, Calif., Aug. 31 ... than to receive." However, when the gift one is giving is ... with more than 97 percent organic aloe vera, receiving and giving ... Founded by Rinaldo and Lalla Brutoco, owners of the manufacturer ...
... say , MONDAY, Aug. 31 (HealthDay News) -- Mass screening ... has led to mass over-diagnosis and over-treatment, a new study ... in 1986, federal government data show that the number of ... said the report in the Aug. 31 online issue of ...
... , MONDAY, Aug. 31 (HealthDay News) -- Walk-in retail clinics ... a new study has found. , Writing in the Sept. ... study author Dr. Ateev Mehrotra said that retail clinics -- ... drug stores and other retail chain stores such as Target ...
... , ABBOTT PARK, Ill., Aug. 31 ... Stanley Global Healthcare Unplugged Conference on Monday, Sept. 14, 2009. ... will make a presentation on the company at 8:10 a.m. Central ... the presentation will be accessible through Abbott,s Investor Relations Web site ...
... , Safety tips also offered as fires threaten ... The American Red Cross is on the scene offering evacuees a safe ... and scorch thousands of acres. Overnight, nearly 200 people took refuge from ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ) , , ...
Cached Medicine News:Health News:Endo Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009 2Health News:It's Better to Give Than to Receive 2Health News:It's Better to Give Than to Receive 3Health News:Prostate Cancer Over-Diagnosed: Study 2Health News:Prostate Cancer Over-Diagnosed: Study 3Health News:Retail Medical Clinics Offer Quality Care: Study 2Health News:Retail Medical Clinics Offer Quality Care: Study 3Health News:Red Cross Shelters Wildfire Evacuees 2Health News:Red Cross Shelters Wildfire Evacuees 3
(Date:6/2/2015)... June 2, 2015 The American Society of ... Practice Guideline for the Use of Medications in the ... ).  The Practice Guideline will assist clinicians ... use. It addresses knowledge gaps about the benefits of ... evidence-based coverage standards by payers. The ...
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/w3n5p6/drug_delivery_in ) ... report "Drug Delivery in Central Nervous System ... their offering. The delivery of drugs ... in the treatment of neurological disorders. Drugs may ... systematically (e.g., by intravenous injection) for targeted action ...
(Date:6/2/2015)... and Markets ( http://www.researchandmarkets.com/research/g5r2nj/surgical_incision ) has announced the addition of ... report to their offering. The report provides ... , Japan , Europe ... , and Rest of World. This report ... Million by the following Product Segments: Stapler Products (Internal Stapler, ...
Breaking Medicine Technology:American Society of Addiction Medicine Releases National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use 2American Society of Addiction Medicine Releases National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use 3Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3Surgical Incision Closures - Global Strategic Business Report 2015 2
... May 5 A voluntary recall has,been issued ... and,labeled with the Cardinal Health brand name. Hydrox ... individual mouthwash bottles and,those contained within Cardinal Health ... and been found positive for Burkholderia,cepacia (B. cepacia). ...
... Delivered Within Pre-Determined ... and Standard Dosing Limitations, BRIDGEWATER, N.J., May 5 ... SoloSTAR(R) disposable insulin pen,prefilled with Lantus(R) (insulin glargine [rDNA ... the pens,accurately delivered all insulin doses within standard limits ...
Cached Medicine Technology:Hydrox Inc., Cardinal Health Issue Nationwide Recall of Alcohol-Free Mouthwash For Hospitals 2New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen 2
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: